全文获取类型
收费全文 | 32138篇 |
免费 | 2995篇 |
国内免费 | 1857篇 |
专业分类
耳鼻咽喉 | 217篇 |
儿科学 | 438篇 |
妇产科学 | 416篇 |
基础医学 | 3899篇 |
口腔科学 | 628篇 |
临床医学 | 4207篇 |
内科学 | 4791篇 |
皮肤病学 | 560篇 |
神经病学 | 1876篇 |
特种医学 | 1184篇 |
外国民族医学 | 24篇 |
外科学 | 3393篇 |
综合类 | 5294篇 |
现状与发展 | 6篇 |
一般理论 | 1篇 |
预防医学 | 1732篇 |
眼科学 | 873篇 |
药学 | 3234篇 |
29篇 | |
中国医学 | 1567篇 |
肿瘤学 | 2621篇 |
出版年
2024年 | 111篇 |
2023年 | 551篇 |
2022年 | 1302篇 |
2021年 | 1642篇 |
2020年 | 1283篇 |
2019年 | 1057篇 |
2018年 | 1168篇 |
2017年 | 1010篇 |
2016年 | 1058篇 |
2015年 | 1514篇 |
2014年 | 1822篇 |
2013年 | 1669篇 |
2012年 | 2490篇 |
2011年 | 2561篇 |
2010年 | 1659篇 |
2009年 | 1273篇 |
2008年 | 1669篇 |
2007年 | 1697篇 |
2006年 | 1673篇 |
2005年 | 1536篇 |
2004年 | 1106篇 |
2003年 | 1016篇 |
2002年 | 871篇 |
2001年 | 728篇 |
2000年 | 732篇 |
1999年 | 693篇 |
1998年 | 398篇 |
1997年 | 385篇 |
1996年 | 283篇 |
1995年 | 254篇 |
1994年 | 269篇 |
1993年 | 155篇 |
1992年 | 204篇 |
1991年 | 174篇 |
1990年 | 183篇 |
1989年 | 132篇 |
1988年 | 117篇 |
1987年 | 99篇 |
1986年 | 90篇 |
1985年 | 85篇 |
1984年 | 39篇 |
1983年 | 21篇 |
1982年 | 31篇 |
1981年 | 22篇 |
1979年 | 25篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1975年 | 13篇 |
1974年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 13 毫秒
1.
社会力量具备相应的经济基础和技术条件,对于公立互联网医院体系建设具有积极的促进作用。但是实践中仍然存在商业模式不完善、监管制度不健全等问题。基于经济学契约理论要义,提出在坚持激励与约束机制并举、平衡公私益关系的前提下,通过完善医保政策、构建互联网医疗服务价格分类管理机制来促进社会力量向医疗服务公益性目标回归,并通过构建完善的监督体制来约束部分社会力量的盲目逐利性行为。 相似文献
2.
3.
4.
Wuteng Cao Huabin Hu Jiao Li Qianyu Wu Lishuo Shi Biao Li Jie Zhou Xinhua Wang Junhong Chen Chao Wang Huaiming Wang Weihao Deng Yan Huang Yanhong Deng 《International journal of cancer. Journal international du cancer》2023,153(11):1894-1903
Neoadjuvant programmed cell death protein 1 (PD-1) blockade exhibits promising efficacy in patients with mismatch repair deficient (dMMR) colorectal cancer (CRC). However, discrepancies between radiological and histological findings have been reported in the PICC phase II trial (NCT 03926338). Therefore, we strived to discern radiological features associated with pathological complete response (pCR) based on computed tomography (CT) images. Data were obtained from the PICC trial that included 36 tumors from 34 locally advanced dMMR CRC patients, who received neoadjuvant PD-1 blockade for 3 months. Among the 36 tumors, 28 (77.8%) tumors achieved pCR. There were no statistically significant differences in tumor longitudinal diameter, the percentage change in tumor longitudinal diameter from baseline, primary tumor sidedness, clinical stage, extramural venous invasion status, intratumoral calcification, peritumoral fat infiltration, intestinal fistula and tumor necrosis between the pCR and non-pCR tumors. Otherwise, tumors with pCR had smaller posttreatment tumor maximum thickness (median: 10 mm vs 13 mm, P = .004) and higher percentage decrease in tumor maximum thickness from baseline (52.9% vs 21.6%, P = .005) compared to non-pCR tumors. Additionally, a higher proportion of the absence of vascular sign (P = .003, odds ratio [OR] = 25.870 [95% CI, 1.357-493.110]), nodular sign (P < .001, OR = 189.000 [95% CI, 10.464-3413.803]) and extramural enhancement sign (P = .003, OR = 21.667 [2.848-164.830]) was observed in tumors with pCR. In conclusion, these CT-defined radiological features may have the potential to serve as valuable tools for clinicians in identifying patients who have achieved pCR after neoadjuvant PD-1 blockade, particularly in individuals who are willing to adopt a watch-and-wait strategy. 相似文献
5.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
6.
<正>随着科技的进步,医疗技术的不断提高,使得诸多影像学检查在临床疾病诊断和治疗工作中发挥了重要作用。20世纪90年代末推出了数字X线成像(digital radiography,DR)成像系统,DR数字影像具有成像质量高,成像速度快,辐射剂量小等优点通过该系统,可以直接将X线信号转换为数字信号,既缩短了拍摄时间,同时由于自带显示系统,医生可以第一时间获得有关患者病情的清晰影像资料,这对于 相似文献
7.
Norwani Basir Pemasari Upali Telisinghe Vui Heng Chong 《The Indian journal of surgery》2015,77(6):545-546
Paraneoplastic pemphigus is a relatively rare but significant acquired autoimmune mucocutaneous disorder that is characterised by diffuse erythema, painful blistering and sores of the skin and mucus membranes. The underlying pathogenesis is believed to be triggered by altered immune system in response to underlying neoplasm. The manifestations can predate, occur at the same time or after the diagnosis of cancer. Associations with gastric cancer have only been reported twice. A 78-year-old lady presented with a month’s history of extensive skin lesions that started off as bullous lesions and biopsy revealed bullous pemphigus. Endoscopy for anemia revealed gastric cancer. This case reinforced the need to consider underlying malignancy in elderly patient with new onset dermatological presentation. 相似文献
8.
9.
我国属胃癌高发国家,且以进展期胃癌为主。以手术和化疗为主的多学科治疗无法有效改善晚期胃癌患者的预后。近年来,免疫检查点抑制剂类药物的疗效在诸多癌症中得到了证实,因此,该类药物在胃癌中的治疗效果也受到了广泛的关注。本文对近年来的相关研究成果进行综述,全面介绍了免疫检查点抑制剂类药物在胃癌治疗中的临床应用情况、联合用药情况以及不良反应。对于其他治疗均失败的晚期胃癌患者,PD-1抑制剂是一个可行的治疗选项,其代表药物派姆单抗是目前唯一被美国食品药品监督管理局批准应用于胃癌治疗的免疫抑制剂类药物,而我国国家食品药品监督管理总局尚未批准任何此类药物应用于胃癌的临床治疗。如何进一步提高治疗的客观缓解率,将会是后续临床和基础研究的一大焦点。 相似文献